Pancreatic Cancer Research

ResearcherUniversity Hospital Schleswig-HolsteinActive in the last 2 years

Steffen Deichmann

Matched on ORCID iD 0000-0002-4985-4723; OpenAlex author ID A5046969660. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 14

  1. Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41698-026-01663-z↗
  2. Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? Co-author DOI 10.3390/cancers18152423↗
  3. An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from the German Cancer Registry Group. Co-author DOI 10.1016/j.ejso.2025.109693↗
  4. The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national re… Co-author DOI 10.1016/j.surg.2023.11.004↗
  5. Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucinous Neoplasm versus Primary Pancreatic D… Last author DOI 10.3390/cancers16112016↗
  6. Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperative symptoms within the DGAV StuDoQ|Pancre… Co-author DOI 10.1016/j.surg.2023.04.042↗
  7. Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jclinpath-2022-208176↗
  8. [Incidence, Treatment and Survival in Pancreatic Cancer- Data of the Nationwide Oncological Quality Conference from a Surgical Perspective]. Co-author DOI 10.1055/a-1768-1012↗
  9. Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenterico-Portal Vein During Pancreatoduodenect… Co-author DOI 10.21873/anticanres.15329↗
  10. Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis. Co-author DOI 10.3791/62541↗
  11. Alignment of stroma fibers, microvessel density and immune cell populations determine overall survival in pancreatic cancer-An analysis of stromal morphology. Co-author DOI 10.1371/journal.pone.0234568↗
  12. Systematic Analysis of Accuracy in Predicting Complete Oncological Resection in Pancreatic Cancer Patients-Proposal of a New Simplified Borderline Resectabilit… Co-author DOI 10.3390/cancers12040882↗
  13. Regulation mechanisms of the hedgehog pathway in pancreatic cancer: a review. Co-author DOI 10.6092/1590-8577/2894↗
  14. Neoadjuvant therapy in pancreatic cancer: review article. Co-author DOI 10.6092/1590-8577/2940↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tobias Keck · 14 shared papers, 2015–2026 · strength 2.00
  2. Kim C. Honselmann · 14 shared papers, 2015–2026 · strength 2.00
  3. Ulrich Friedrich Wellner · 14 shared papers, 2015–2026 · strength 2.00
  4. Louisa Bolm · 12 shared papers, 2020–2026 · strength 1.89
  5. Rüdiger Braun · 10 shared papers, 2021–2026 · strength 1.69
  6. Hryhoriy V. Lapshyn · 9 shared papers, 2020–2026 · strength 1.39
  7. Thaer S. A. Abdalla · 4 shared papers, 2024–2026 · strength 0.75
  8. Lennart von Fritsch · 3 shared papers, 2024–2026 · strength 0.58
  9. Dirk Bausch · 4 shared papers, 2015–2021 · strength 0.32
  10. Ekaterina Petrova · 3 shared papers, 2020–2021 · strength 0.32
  11. Natalie Petruch · 2 shared papers, 2021–2024 · strength 0.29
  12. Oliver Schilling · 2 shared papers, 2021–2023 · strength 0.28
  13. Birte Kulemann · 2 shared papers, 2021–2022 · strength 0.25
  14. Benjamin Heckelmann · 1 shared paper, 2026 · strength 0.22
  15. Corinna Ulrike Keber · 1 shared paper, 2026 · strength 0.22
  16. Christoph Röcken · 1 shared paper, 2026 · strength 0.22
  17. Jens Uwe Marquardt · 1 shared paper, 2026 · strength 0.22
  18. Anna Maxi Wandmacher · 1 shared paper, 2026 · strength 0.22
  19. Benedikt Färber · 1 shared paper, 2026 · strength 0.22
  20. Annika Bräuer · 1 shared paper, 2026 · strength 0.22
  21. Susanne Sebens · 1 shared paper, 2026 · strength 0.22
  22. Carlos F. Fernandez-del Castillo · 1 shared paper, 2024 · strength 0.17
  23. Maximiliano Servín-Rojas · 1 shared paper, 2024 · strength 0.17
  24. Motaz Qadan · 1 shared paper, 2024 · strength 0.17
  25. Keith D. Lillemoe · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.